These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6184944)

  • 1. Modification of rat brain 5-hydroxytryptamine metabolism by sublethal doses of organophosphate agents.
    Prioux-Guyonneau M; Coudray-Lucas C; Coq HM; Cohen Y; Wepierre J
    Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):278-84. PubMed ID: 6184944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of physostigmine, paraoxon and soman on brain GABA level and metabolism.
    Coudray-Lucas C; Prioux-Guyonneau M; Sentenac H; Cohen Y; Wepierre J
    Acta Pharmacol Toxicol (Copenh); 1984 Aug; 55(2):153-7. PubMed ID: 6496115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of intoxication by anticholinesterase agents on core temperature in rats: relationships between hypothermia and acetylcholinesterase inhibition in different brain areas.
    Coudray-Lucas C; Prioux-Guyonneau M; Tassel A; Coq HM; Cohen Y; Wepierre J
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):215-22. PubMed ID: 7336979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophol-induced change in Brain 5-hydroxytryptamine Metabolism.
    Fukumori R; Minegishi A; Satoh T; Kitagawa H; Yanaura S
    Psychopharmacology (Berl); 1980; 69(3):243-6. PubMed ID: 6158066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a single dose and prolonged benzene administration on 5-hydroxytryptamine and 5-hydroxyindolacetic acid content in rat brain.
    Paradowski M; Heimburger M; Cohen Y; Andrzejewski S
    Xenobiotica; 1984 Oct; 14(10):781-4. PubMed ID: 6209865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo.
    O'Connell MT; Portas CM; Sarna GS; Curzon G
    Br J Pharmacol; 1991 Apr; 102(4):831-6. PubMed ID: 1713108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated choline levels in brain. A non-cholinergic component of organophosphate toxicity.
    Flynn CJ; Wecker L
    Biochem Pharmacol; 1986 Sep; 35(18):3115-21. PubMed ID: 3753519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the antiepileptic di-n-propylacetamide on 5-hydroxytryptamine turnover in the brain and 5-hydroxyindoleacetic acid level in the cerebrospinal fluid.
    Whitton PS; Oresković D; Marković Z; Skarpa D; Bulat M
    Eur J Pharmacol; 1983 Jul; 91(1):57-62. PubMed ID: 6193970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat.
    Clement JG
    Biochem Pharmacol; 1982 Apr; 31(7):1283-7. PubMed ID: 7092921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain catecholamine metabolism changes and hypothermia in intoxication by anticholinesterase agents.
    Coudray-Lucas C; Prioux-Guyonneau M; Sentenac H; Cohen Y; Wepierre J
    Acta Pharmacol Toxicol (Copenh); 1983 Mar; 52(3):224-9. PubMed ID: 6846031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of brain 5-hydroxytryptamine turnover in freely moving rats using repeated sampling of cerebrovascular fluid.
    Sarna GS; Hutson PH; Tricklebank MD; Curzon G
    J Neurochem; 1983 Feb; 40(2):383-8. PubMed ID: 6185635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A striatal serotonergic involvement in the behavioural effects of anticholinesterase organophosphates.
    Fernando JC; Hoskins BH; Ho IK
    Eur J Pharmacol; 1984 Feb; 98(1):129-32. PubMed ID: 6201369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of soman after repetitive injection of sublethal doses in rat.
    Sterri SH; Lyngaas S; Fonnum F
    Acta Pharmacol Toxicol (Copenh); 1980 Jan; 46(1):1-7. PubMed ID: 7361558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass fragmentographic determination of 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid in brain tissue using deuterated internal standards.
    Beck O; Wiesel FA; Sedvall G
    J Chromatogr; 1977 Apr; 134(2):407-14. PubMed ID: 140179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of p-chlorophenylalanine at moderate dosage on 5-HT and 5-HIAA concentrations in brain regions of control and p-chloroamphetamine treated rats.
    Datla KP; Curzon G
    Neuropharmacology; 1996 Mar; 35(3):315-20. PubMed ID: 8783206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 causes sedation and increases 5-hydroxytryptamine turnover in rat brain.
    Haubrich DR; Perez-Cruet J; Reid WD
    Br J Pharmacol; 1973 May; 48(1):80-7. PubMed ID: 4269288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral metabolic effects of organophosphorus anticholinesterase compounds.
    Miller AL; Medina MA
    Metab Brain Dis; 1986 Jun; 1(2):147-56. PubMed ID: 3508239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intrastriatal injection of soman on acetylcholine, dopamine and serotonin metabolism.
    Robinson SE; Hambrecht KL
    Life Sci; 1988; 42(23):2331-9. PubMed ID: 3374262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soman and sarin induce a long-lasting naloxone-reversible analgesia in mice.
    Clement JG; Copeman HT
    Life Sci; 1984 Apr; 34(15):1415-22. PubMed ID: 6708739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain.
    Shih TM
    Psychopharmacology (Berl); 1982; 78(2):170-5. PubMed ID: 6817374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.